MLMo Li

Mo Li

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Mo Li has a total of 45 co-authors. Here are the top co-authors by number of shared publications:

  • Huaiqiu Zhu

    Department of Biomedical Engineering, College of Future Technology, and Center for Quantitative Biology, Peking University, Beijing, China

    6 shared publications
  • Xiaoqing Jiang

    Department of Biomedical Engineering, and Department of Big Data and Biomedical AI, College of Future Technology, and Center for Quantitative Biology, Peking University, Beijing 100871, China

    6 shared publications
  • Jinyuan Guo

    Department of Biomedical Engineering, and Department of Big Data and Biomedical AI, College of Future Technology, and Center for Quantitative Biology, Peking University, Beijing 100871, China

    4 shared publications
  • Qian Guo

    Department of Biomedical Engineering, and Department of Big Data and Biomedical AI, College of Future Technology, and Center for Quantitative Biology, Peking University, Beijing 100871, China

    4 shared publications
  • Chunhui Wang

    Department of Biomedical Engineering, College of Future Technology, and Center for Quantitative Biology, and Center of Artificial Intelligence for Digital Life, Peking University, Beijing, China, 100871

    3 shared publications
  • Jie Tan

    Department of Biomedical Engineering, College of Future Technology, and Center for Quantitative Biology, Peking University, Beijing 100871, China

    3 shared publications

Latest Publications

  • Open Access

    Reply to Takada and Komine-Aizawa, “Bacterial vaginosis and the gut-vagina axis”

    by Mo Li, Qianyu Zhang, Tong Wu, Dianxing Hu, Shixuan Wang, Jinjin Zhang

  • Open Access

    eBiota: Designing microbial communities from large seed pools with desired function using rapid optimization and deep learning

    by Xiaoqing Jiang, Jiaheng Hou, Haoyu Zhang, Jinyuan Guo, Shaohua Gu, Doris Vandeputte, Yulin Liao, Qian Guo, Xinrun Yang, Yiyan Zhou, et al.

    Designing microbial communities to generate target products is crucial for biotechnology, agriculture, and disease treatment. However, rationally designing such communities from large seed pools has become a major challenge, as the rapidly expanding number of complete microbial genomes greatly expands the search space and sharply increases the required screening time and computational cost. Here, we introduce eBiota, a platform for ab initio design of microbial communities from a pool of 21,514 strains to generate target products. eBiota not only identifies optimal strain combinations but also simulates community behaviors, including microbial interactions and relative abundances. eBiota integrates three modules: CoreBFS, a graph-based search algorithm that rapidly screens for bacteria with complete metabolic pathways related to the target product; ProdFBA, an extended flux balance analysis that identifies microbial consortia with maximal production efficiency; and DeepCooc, a deep learning model trained on 23,323 microbiome samples across various environments to infer co-occurrence patterns. We validated eBiota’s capabilities in microbial community design and production efficiency calculation using public microbiome datasets, ranging from single strains to six-member consortia. Further in vitro experiments involving 94 strains confirmed eBiota’s ability to identify species that inhibit pathogen growth and to accurately model the relative abundances within complex microbial communities. As an initial digital twin, eBiota provides a powerful platform for the rational design of functional microbial communities, offering new opportunities for metabolic engineering and synthetic biology.


  • Open Access

    Deciphering gene redundancy in prokaryotic genomes provides evolutionary insights for pathogenicity and its roles in clinical infections

    by Peihong Wang, Qian Guo, Xiaoqing Jiang, Ping Lu, Mengru Chang, Longshu Yang, Mo Li, Chunhui Wang, Tingting Xiao, Yonghong Xiao, et al.

    Gene redundancy, increasing gene dosage and functional diversity, remains understudied regarding its roles in evolution and clinical infections. Exploring 22,310 prokaryotic genomes with our custom pipeline, we found that redundant genes, though less frequent than in eukaryotes, are widespread and mainly linked to niche specialization. Evolutionary analyses delineated a propensity for gene redundancy expansion with increasing phylogenetic distance, with pathogens accumulating more redundancy than non-pathogens. Redundant genes are always co-duplicated with translation initiation signals and potentially preserve functionality. Time series examining 69 Acinetobacter baumannii isolates from multi-sites in severely infected patients, we identified redundant alcohol dehydrogenase genes and translation initiation signals, introduced by gene islands, as advantageous for invasive urinary tract infection throughout its within-patient development and cross-patient transmission. Mouse peritoneal infection models and plasmid transformation experiments confirmed that the redundancy of frmA, an alcohol dehydrogenase gene, is linked to both enhanced virulence and increased biofilm mass in Acinetobacter baumannii. Additional analysis of 898 Enterobacter cloacae complex genomes revealed that redundant metal ion resistance genes carried by mobile genetic elements may provide selective advantages. This study unveiled a moderate gene redundancy within prokaryotes, providing genetic insights into the adaptive evolution and clinical infection of pathogens.


  • Open Access

    Developing Foundation Models for Predicting Viral Animal Host Range in Intelligent Surveillance

    by Jinyuan Guo, Qian Guo, Hengchuang Yin, Yilun Han, Peter X. Geng, Jiaheng Hou, Haoyu Zhang, Jie Tan, Mo Li, Yan Zhang, et al.

    Emerging human infectious viruses originating from animals continue to pose a persistent threat to global public health. Understanding the host range of animal viruses is crucial for identifying potential spillover pathways and mitigating the risk of future pandemics. Here, we present VirHRanger, a prediction method that integrates foundation models trained on viral genome and protein sequences, alongside genomic and protein compositional traits, viral phylogeny, and protein-protein interactions. To systematically predict the animal host range, VirHRanger incorporates host taxonomy-aware neural networks trained on a comprehensive collection of animal-virus associations spanning mammals, birds, and arthropods. Within a dataset of 4,006 virus species spanning 99 viral families, our model achieved robust performance with a micro-averaged AUROC of 0.938 across all host categories, demonstrating its effectiveness in capturing generalizable host signals from viral genetic data. On a dataset of 315 novel viruses, which are associated with key reservoir animal hosts and insect vectors, VirHRanger notably outperformed the homology-based method, exhibiting a strong generalizability to novel viruses. Furthermore, VirHRanger identified host range variations among closely related viruses within the Coronaviridae family and successfully predicted the ability of SARS-CoV-2 to infect humans and other animal hosts. These findings highlight the potential of VirHRanger to transform sequencing data into timely insights for disease control during the early stages of zoonotic outbreaks.


  • Open Access

    IPEV: identification of prokaryotic and eukaryotic virus-derived sequences in virome using deep learning

    by Hengchuang Yin, Shufang Wu, Jie Tan, Qian Guo, Mo Li, Jinyuan Guo, Yaqi Wang, Xiaoqing Jiang, Huaiqiu Zhu

    Background: The virome obtained through virus-like particle enrichment contains a mixture of prokaryotic and eukaryotic virus-derived fragments. Accurate identification and classification of these elements are crucial to understanding their roles and functions in microbial communities. However, the rapid mutation rates of viral genomes pose challenges in developing high-performance tools for classification, potentially limiting downstream analyses. Findings: We present IPEV, a novel method to distinguish prokaryotic and eukaryotic viruses in viromes, with a 2-dimensional convolutional neural network combining trinucleotide pair relative distance and frequency. Cross-validation assessments of IPEV demonstrate its state-of-the-art precision, significantly improving the F1-score by approximately 22% on an independent test set compared to existing methods when query viruses share less than 30% sequence similarity with known viruses. Furthermore, IPEV outperforms other methods in accuracy on marine and gut virome samples based on annotations by sequence alignments. IPEV reduces runtime by at most 1,225 times compared to existing methods under the same computing configuration. We also utilized IPEV to analyze longitudinal samples and found that the gut virome exhibits a higher degree of temporal stability than previously observed in persistent personal viromes, providing novel insights into the resilience of the gut virome in individuals. Conclusions: IPEV is a high-performance, user-friendly tool that assists biologists in identifying and classifying prokaryotic and eukaryotic viruses within viromes. The tool is available at https://github.com/basehc/IPEV.


  • Open Access

    Global Meta-analysis of Airborne Bacterial Communities and Associations with Anthropogenic Activities

    by Xiaoqing Jiang, Chunhui Wang, Jinyuan Guo, Jiaheng Hou, Xiao Guo, Haoyu Zhang, Jie Tan, Mo Li, Xin Li, Huaiqiu Zhu

    Airborne microbiome alterations, an emerging global health concern, have been linked to anthropogenic activities in numerous studies. However, these studies have not reached a consensus. To reveal general trends, we conducted a meta-analysis using 3226 air samples from 42 studies, including 29 samples of our own. We found that samples in anthropogenic activity-related categories showed increased microbial diversity, increased relative abundance of pathogens, increased co-occurrence network complexity, and decreased positive edge proportions in the network compared with the natural environment category. Most of the above conclusions were confirmed using the samples we collected in a particular period with restricted anthropogenic activities. Additionally, unlike most previous studies, we used 15 human-production process factors to quantitatively describe anthropogenic activities. We found that microbial richness was positively correlated with fine particulate matter concentration, NH3 emissions, and agricultural land proportion and negatively correlated with the gross domestic product per capita. Airborne pathogens showed preferences for different factors, indicating potential health implications. SourceTracker analysis showed that the human body surface was a more likely source of airborne pathogens than other environments. Our results advance the understanding of relationships between anthropogenic activities and airborne bacteria and highlight the role of airborne pathogens in public health.


  • Open Access

    Gut Microbiota‐Related Effects of Tanhuo Decoction in Acute Ischemic Stroke

    by Qian Guo, Xiaoqing Jiang, Can Ni, Linjing Li, Li Chen, Yaqi Wang, Mo Li, Chunhui Wang, Li Gao, Huaiqiu Zhu, et al.

    Acute ischemic stroke (AIS) is a major cause of acquired adult disability and death. Our previous studies proved the efficacy and effectiveness of Tanhuo decoction (THD) on AIS. However, the therapeutic mechanism remains unclear. We recruited 49 AIS patients and 30 healthy people to explore the effects of THD+basic treatment on the poststroke gut microbiota of AIS patients using 16S rRNA sequencing, in which 23 patients received basic treatment (control group) and 26 patients received THD+basic treatment (THD group). By comparing the data before and after treatments, we found the THD group acquired better outcome than the control group on both clinical outcome indices and the characteristics of gut microbiota. In addition to the mediation on short‐chain fatty acid‐ (SCFA‐) producing bacteria in two groups, treatment in the THD group significantly decreased the lipopolysaccharide‐ (LPS‐) producing bacteria to reduce LPS biosynthesis. Besides, the complexity of the cooccurrence of gut microbiota and the competition among LPS‐producing bacteria and opportunistic pathogenetic bacteria were enhanced in the THD group. Treatment in the THD group also exhibited the potential in decreasing genes on the biosynthesis of trimethylamine (TMA), the precursor of Trimethylamine N‐oxide (TMAO), and increasing genes on the degradation of TMA, especially increasing trimethylamine‐corrinoid protein Co‐methyltransferase (mttB) which catabolizes TMA to methane. These results hinted that THD+basic treatment might exert its efficacy by mediating the gut microbiota and microbial metabolites, including LPS and TMAO that aggravate the sterile inflammation and platelet aggregation. Moreover, the well‐fitting regression model results in predicting the clinical outcome with the alteration of gut microbiota proved gut microbiota as a potential indicator of AIS and provided evidence of the communication between the gut and brain of AIS patients.